tiprankstipranks
Holding GB:I50D?
Track your performance easily

GB:I50D ETF Forecast & Price Targets

See the Price Targets and Ratings of:

I50D Analyst Ratings

Moderate Buy
336ConsensusRatings
276 Buy
56 Hold
4 Sell
Based on the consensus analyst ratings on 336 stocks held in GB:I50D.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

I50D 12 Month Forecast

Average Price Target

580.80p
Based on 336 Wall Street analysts offering 12 month price targets to GB:I50D holdings in the last 3 months. The average price target is 580.80p with a high forecast of 682.89p and a low forecast of 473.67p. The average price target represents a 11.31% change from the last price of 521.80p.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"472":"472p","683":"683p","524.75":"524.8p","577.5":"577.5p","630.25":"630.3p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":682.886,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">682.89p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":580.802,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">580.80p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":473.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">473.67p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[472,524.75,577.5,630.25,683],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Jun<br/>2024","9":"Sep<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,498.72,512.8866153846154,527.0532307692308,541.2198461538462,555.3864615384615,569.5530769230769,583.7196923076923,597.8863076923077,612.0529230769231,626.2195384615385,640.3861538461538,654.5527692307692,668.7193846153846,{"y":682.886,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,498.72,505.03400000000005,511.348,517.662,523.976,530.2900000000001,536.604,542.918,549.232,555.546,561.86,568.174,574.488,{"y":580.802,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,498.72,496.79307692307697,494.86615384615385,492.9392307692308,491.01230769230773,489.0853846153846,487.15846153846155,485.2315384615385,483.30461538461543,481.3776923076923,479.45076923076925,477.5238461538462,475.5969230769231,{"y":473.67,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":479.36,"date":1701388800000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1704067200000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1706745600000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1709251200000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1711929600000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1714521600000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1717200000000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1719792000000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1722470400000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1725148800000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":479.36,"date":1727136000000,"info":"<div>Price: <b>479p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":481.75,"date":1727740800000,"info":"<div>Price: <b>482p<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":498.72,"date":1730419200000,"info":"<div>Price: <b>499p<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target682.89pAverage Price Target580.80pLowest Price Target473.67p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

I50D Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Moderna
6 Buy
11 Hold
3 Sell
Hold
$77.35
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Genmab A/S
6 Buy
0 Hold
0 Sell
Strong Buy
$2,508.17
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Biomarin Pharmaceutical Inc.
20 Buy
7 Hold
0 Sell
Moderate Buy
$98.52
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Biogen Inc.
14 Buy
11 Hold
0 Sell
Moderate Buy
$247.59
xxxxxxxxxxxxxxxxxxxxxxxxxxx
First Solar
20 Buy
4 Hold
0 Sell
Strong Buy
$277.05

I50D Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF
Please check back later or explore other ETFs for potential investment opportunities.

I50D ETF FAQ

What is GB:I50D’s average 12-month price target, according to analysts?
Based on analyst ratings, GB:I50D’s 12-month average price target is 580.80p.
    What is GB:I50D’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GB:I50D, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is GB:I50D a Buy, Sell or Hold?
        GB:I50D has a consensus rating of Moderate Buy which is based on 276 buy ratings, 56 hold ratings and 4 sell ratings.
          What is GB:I50D’s price target?
          The average price target for GB:I50D is 580.80p. This is based on 336 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is 682.89p ,the lowest forecast is 473.67p. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about GB:I50D?
            GB:I50D’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 336 Wall Streets Analysts.
              How can I buy shares of GB:I50D?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis